Corn Products International Inc. Sep 11

  • ID: 1922365
  • September 2011
  • Region: Global
  • Standard & Poors
1 of 3

Leading corn refiner, with emphasis on specialty products; Improved market position following the recent acquisition of National Starch; and Ability to hedge a meaningful portion of its raw material costs. Highly competitive, commodity-oriented business; and Exposure rising corn costs. The ratings on Westchester, Ill.-based Corn Products International Inc. reflect a satisfactory business risk profile and intermediate financial risk profile. Standard & Poor's Ratings Services believes Corn Products' business risk profile has strengthened following the acquisition of National Starch, and regional and product diversification has improved, resulting in more value-added offerings, a larger presence in processed foods ingredients, and better research and development (R&D) capabilities. Moreover, given the similar market segments in which both companies operate, integration of Corn Products and...

Companies mentioned in this report are: Corn Products International Inc.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Corn Products International Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.